Lori Macomber
Director Financiero/CFO en LEGEND BIOTECH CORPORATION .
Fortuna: 225 216 $ al 31/05/2024
Perfil
Lori Macomber is currently the Chief Financial Officer at Legend Biotech Corp.
She previously worked as the Business Unit Controller at AMETEK, Inc. from 2018 to 2019, the Assistant VP-Finance Site Leader at Eli Lilly & Co. from 2010 to 2017, and the Controller & Chief Financial Officer-US Region at Cello Health Ltd.
from 2017 to 2018.
Ms. Macomber obtained her undergraduate degree from The Pennsylvania State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
0.00% | 31/12/2023 | 11 258 ( 0.00% ) | 225 216 $ | 31/05/2024 |
Cargos activos de Lori Macomber
| Empresas | Cargo | Inicio |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Director Financiero/CFO | 09/05/2022 |
Antiguos cargos conocidos de Lori Macomber.
| Empresas | Cargo | Fin |
|---|---|---|
| AMETEK, INC. | Corporate Officer/Principal | 01/09/2019 |
| CELLO HEALTH PLC | Comptroller/Controller/Auditor | 01/02/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/04/2017 |
Formación de Lori Macomber.
| The Pennsylvania State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| AMETEK, INC. | Producer Manufacturing |
| ELI LILLY AND COMPANY | Health Technology |
| Empresas privadas | 1 |
|---|---|
Cello Health Ltd.
 Cello Health Ltd. Miscellaneous Commercial ServicesCommercial Services Cello Health Plc provides strategic marketing services. It operates through two segments: Cello Health and Cello signal. The Cello Health segment provides market research, consulting, and communications services principally to its pharmaceutical and healthcare clients and Signal segment provides market research and direct communications services principally to its consumer facing clients. The company was founded by Mark Coleridge Scott and Kevin Barrie Steeds on May 5, 2004 and is headquartered in London, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Lori Macomber
